Leadinno Medical Valley

About Leadinno Medical Valley

Based in Beijing, Leadinno Medical Valley, formally known as Beijing Lingchuang Medical Valley Technology Development Co., Ltd., was established in 2016 to develop and commercialize medical devices, with a specific focus on neuromodulation and pain management. The company operates in the therapeutic devices industry, targeting the healthcare sector with its products.

The company's scientific leadership includes Academician Jisheng Han, a foundational figure in China's neuromodulation field, and Professor Bifa Fan, a prominent leader in pain science technology, who both serve as chief scientists. This expertise guides the firm's strategic direction in creating solutions for chronic pain. Leadinno's business model revolves around the research, development, production, and sale of its medical devices. The company has successfully raised significant capital to fund these activities, including a Series A round of over CNY 100 million in September 2022 and a Series A+ round of over RMB 100 million in October 2023. These funds are allocated to product R&D, manufacturing, team expansion, and general operations.

Leadinno Medical Valley has developed a wireless, portable implantable neurostimulation product, the InnoPulse-SCS, which was poised to enter clinical trials. This product utilizes wireless energy-carrying technology to address limitations found in traditional implantable neurostimulators. The company is also expanding its product line to include peripheral nerve stimulation (PNS) products. In addition to neuromodulation, the company has a presence in the minimally invasive spine surgery market through its subsidiary, Tianjin Leading Innovation Medical Wisdom Co., Ltd. This division focuses on spinal endoscopy technology, with products like the SpineInno-TOP and SpineInno-UBE systems already approved in China. Other products in this line include various types of forceps and spinal endoscopes.